News

Illuminating public buildings in red, candlelight vigils, and walks are among events planned for World Sickle Cell Day, June ...
Columnist Mary Shaniqua shares the benefits of attending the European Hematology Association's 2025 Congress as a sickle cell patient.
In honor of this year's World Sickle Cell Day, columnist Dunstan Nicol-Wilson recognizes several organizations that are making a difference.
BEAM-101, a genetically modified cell therapy for sickle cell, is designed to turn on HbF to counteract mutated adult ...
Even if children with sickle cell disease appear asymptomatic, it's still crucial to provide proper care, says columnist.
For columnist Mary Shaniqua, who tracks her health closely, not being able to discern the causes of a sickle cell crisis is ...
This is despite vaccinations for SCD children against the pneumococcal bacteria that cause meningitis and other diseases. Per the researchers, this study demonstrated that, in most cases, meningitis ...
An ongoing, early-phase clinical trial of pociredir, an oral small molecule being developed by Fulcrum Therapeutics as a possible treatment for sickle cell disease (SCD), is still recruiting adult ...